¥31.63
¥0.00 (0.00%)
End-of-day quote: 06/01/2024
SZSE:000963

Huadong Medicine Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Rev. Revenue
¥40.62B ¥37.71B ¥34.56B ¥33.68B ¥35.45B ¥30.66B ¥27.83B ¥21.73B ¥18.95B ¥16.72B ¥14.58B ¥11.13B ¥8.97B ¥7.82B ¥6.02B ¥4.85B ¥3.97B
GM % Gross Margin %
32.38% 31.89% 30.65% 33.04% 32.06% 28.98% 26.12% 23.98% 21.97% 20.18% 19.54% 19.63% 18.76% 19.98% 19.36% 21.41% 19.98%
OM Operating Margin
8.84% 8.36% 8.12% 8.98% 8.99% 9.39% 8.22% 7.27% 6.88% 6.21% 6.25% 6.35% 5.74% 7.44% 5.98% 7.37% 5.39%
EPS Earnings Per Share
¥0.00 ¥1.56 ¥1.38 ¥1.25 ¥1.39 ¥1.47 ¥1.28 ¥0.99 ¥0.68 ¥0.47 ¥0.35 ¥0.30 ¥0.24 ¥0.19 ¥0.23 ¥0.11 ¥0.11 ¥0.05
Div. Dividends
¥0.58 ¥0.29 ¥0.29 ¥0.23 ¥0.28 ¥0.28 ¥0.40 ¥0.35 ¥0.26 ¥0.19 ¥0.17 ¥0.09 ¥0.09 ¥0.09 ¥0.00 ¥0.00 ¥0.04
PR % Payout Ratio %
37.18% 21.01% 23.20% 16.55% 19.05% 21.88% 40.40% 51.47% 55.32% 54.29% 56.67% 37.50% 47.37% 39.13% 0.00% 0 80.00%
Sha. Shares
1751.81m 1749.81m 1749.81m 1749.81m 1749.81m 1749.81m 1749.81m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m 1562.62m
OCF Operating Cash Flow
¥3.93B ¥2.38B ¥3.17B ¥3.41B ¥2.00B ¥2.04B ¥1.66B ¥658.54M ¥740.85M ¥476.98M ¥642.73M ¥24.57M ¥-27.99M ¥567.94M ¥344.69M ¥265.79M ¥68.38M
FCF Free Cash Flow
¥1.89B ¥1.20B ¥2.35B ¥1.94B ¥648.26M ¥1.17B ¥1.18B ¥275.53M ¥416.74M ¥141.14M ¥385.76M ¥-199.64M ¥-198.85M ¥438.68M ¥256.45M ¥233.52M ¥-15.15M
FCFS Free Cash Flow Per Share
¥1.33 ¥0.68 ¥1.34 ¥1.11 ¥0.37 ¥0.66 ¥0.68 ¥0.18 ¥0.27 ¥0.09 ¥0.25 ¥-0.13 ¥-0.13 ¥0.28 ¥0.16 ¥0.15 ¥-0.01